Salarius Pharmaceuticals, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Salarius Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Salarius Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was -140 %, a 40.8% increase year-over-year.
  • Salarius Pharmaceuticals, Inc. annual Return On Equity for 2023 was -198 %, a 43% decline from 2022.
  • Salarius Pharmaceuticals, Inc. annual Return On Equity for 2022 was -138 %, a 377% decline from 2021.
  • Salarius Pharmaceuticals, Inc. annual Return On Equity for 2021 was -29 %, a 23.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -198 -59.5 -43% Jan 1, 2023 Dec 31, 2023
2022 -138 -109 -377% Jan 1, 2022 Dec 31, 2022
2021 -29 +8.87 +23.4% Jan 1, 2021 Dec 31, 2021
2020 -37.9 +83.9 +68.9% Jan 1, 2020 Dec 31, 2020
2019 -122 -214 -232% Jan 1, 2019 Dec 31, 2019
2018 92 +198 Jan 1, 2018 Dec 31, 2018
2017 -106 -50.4 -90.7% Jan 1, 2017 Dec 31, 2017
2016 -55.6 -26.8 -93% Jan 1, 2016 Dec 31, 2016
2015 -28.8 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.